J K Simon

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults
    Jakub K Simon
    Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Hum Vaccin 3:54-8. 2007
  2. ncbi Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates
    J K Simon
    Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, United States
    Vaccine 27:565-72. 2009
  3. ncbi Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates
    J K Simon
    Division of Infectious Diseases and Tropical Pediatrics, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
    Clin Immunol 139:185-92. 2011
  4. ncbi Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media
    Karen L Kotloff
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Hum Vaccin 3:268-75. 2007
  5. ncbi Immunology of gut mucosal vaccines
    Marcela F Pasetti
    Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore St, Room 480, Baltimore, MD 21201, USA
    Immunol Rev 239:125-48. 2011
  6. ncbi Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine
    Jakub K Simon
    Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, MD 21201, USA
    Clin Vaccine Immunol 18:355-61. 2011
  7. ncbi Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens
    L R Stanberry
    Department of Pediatrics, Columbia University, New York, NY, USA
    Vaccine 30:307-16. 2012

Research Grants

  1. Immunological Correlates of Protection in Shigellosis
    Jakub Simon; Fiscal Year: 2007

Detail Information

Publications7

  1. ncbi A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults
    Jakub K Simon
    Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Hum Vaccin 3:54-8. 2007
    ..Mucosal administration of currently licensed measles vaccine has been proposed to address issues of needle safety and improve vaccine uptake...
  2. ncbi Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates
    J K Simon
    Division of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, United States
    Vaccine 27:565-72. 2009
    ..In sum, oral vaccination with live-attenuated S. flexneri 2a elicits B(M) cells to LPS and IpaB, suggesting that B(M) responses to Shigella antigens should be further studied as a suitable surrogate of protection in shigellosis...
  3. ncbi Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates
    J K Simon
    Division of Infectious Diseases and Tropical Pediatrics, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
    Clin Immunol 139:185-92. 2011
    ..These B(M) cell responses are likely play an important role in modulating the magnitude and longevity of the humoral response...
  4. ncbi Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media
    Karen L Kotloff
    Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Hum Vaccin 3:268-75. 2007
    ....
  5. ncbi Immunology of gut mucosal vaccines
    Marcela F Pasetti
    Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore St, Room 480, Baltimore, MD 21201, USA
    Immunol Rev 239:125-48. 2011
    ..This review dissects the immune responses elicited in humans by enteric vaccines...
  6. ncbi Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine
    Jakub K Simon
    Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, MD 21201, USA
    Clin Vaccine Immunol 18:355-61. 2011
    ....
  7. ncbi Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens
    L R Stanberry
    Department of Pediatrics, Columbia University, New York, NY, USA
    Vaccine 30:307-16. 2012
    ..We assessed the safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W(80)5EC combined with approved seasonal influenza antigens...

Research Grants2

  1. Immunological Correlates of Protection in Shigellosis
    Jakub Simon; Fiscal Year: 2007
    ..abstract_text> ..